Correction: Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection.
Beitelshees AL, Stevenson JM, El Rouby N, Dillon C, Empey PE, Fielstein EM, Johnson JA, Limdi NA, Ong HH, Franchi F, Angiolillo DJ, Peterson JF, Rosenman MB, Skaar TC, Tuteja S, Cavallari LH; IGNITE Pharmacogenetics Working Group.
Beitelshees AL, et al. Among authors: angiolillo dj.
Genet Med. 2020 Nov;22(11):1919. doi: 10.1038/s41436-020-0931-1.
Genet Med. 2020.
PMID: 32747766
Free article.